摘要
目的:探讨当归汤剂治疗支气管哮喘的临床效果。方法:本研究开展时间为2015年10月-2016年10月,收集支气管哮喘患者120例作为研究对象,对照组采用西医治疗法进行治疗,观察组在西医治疗的基础上,采用当归汤剂进行治疗。观察和比较两组患者的临床治疗效果、不良反应发生率和治疗前后的呼吸功能。结果:与对照组治疗有效率(66.67%)对比,观察组(93.33%)明显更高,数据比较差异具有统计学意义,P<0.05。与对照组不良反应发生率(5.00%)对比,观察组(16.67%)明显更低,数据比较差异具有统计学意义,P<0.05。组内比较,观察组、对照组治疗前后各项呼吸功能指标比较差异显著,具有统计学意义(P<0.05);组间比较,观察组治疗后PEFR、FEV1、MVV均高于对照组治疗后,Raw低于对照组治疗后,差异显著,有统计学意义(P<0.05)。结论:当归汤剂治疗支气管哮喘的临床效果显著,能够有效地改善患者的呼吸功能,不良反应少,值得临床广泛应用。
Objective:To explore effects of the Danggui decoction on bronchial asthma.Methods:120cases were divided into two groups.The control group was given western medicine.The observation group was treated with the Danggui decoction more.The efficacy,adverse reactions and the respiratory function were compared.Results:The efficiency in the observation group was93.33%,and significantly higher than66.67%in the control group,P<0.05.The adverse reaction in the observation group was16.67%,and significantly lower than5.00%in the control group,P<0.05.There were differences of respiratory function indexes between both groups and between before and after treatment.PEFR,FEV1,MVV were better and Raw was lower in the observation group(P<0.05).Conclusion:The Danggui decoction was effective on bronchial asthma,by effectively improving the respiratory function,with fewer adverse reactions,is worthy of clinical application.
出处
《中医临床研究》
2017年第22期61-62,共2页
Clinical Journal Of Chinese Medicine
关键词
当归汤剂
支气管哮喘
临床治疗
The Danggui decoction
Bronchial asthma
Clinical treatment
